Why the study?
The relationship between concentric left ventricular hypertrophy (cLVH) at peritoneal dialysis (PD) initiation and patient prognosis remained unclear.
Does concentric left ventricular hypertrophy at peritoneal dialysis initiation predict mortality and MACE in adult patients?
Population
131 patients undergoing echocardiography during the PD initiation period
Comparison
cLVH vs non-cLVH at PD initiation
Design
Retrospective cohort study
Authors
Loading...
cLVH at PD initiation was associated with mortality; hypothesis-generating and requires prospective validation before guiding risk stratification.
Does concentric left ventricular hypertrophy at peritoneal dialysis initiation predict mortality and MACE in adult patients?
Concentric left ventricular hypertrophy at peritoneal dialysis initiation is an independent predictor of all-cause mortality and major adverse cardiovascular events.
Tomura et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: